AstraZeneca to buy vaccine developer Icosavax for $1.1bn

Pharmaceutical company AstraZeneca said on Tuesday it had agreed to buy infectious disease vaccine developer Icosavax in a deal worth up to $1.1bn to support its respiratory syncytial virus vaccine.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM